Drug Profile


Alternative Names: Aflen; Disgren; Tecnosal; Triflux; UR 1501

Latest Information Update: 03 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Uriach
  • Class Antiplatelets; Salicylates
  • Mechanism of Action Cyclooxygenase inhibitors; Platelet aggregation inhibitors; Thromboxane A2 synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Myocardial infarction; Thromboembolism; Unstable angina pectoris
  • Discontinued Alzheimer's disease; Dementia; Stroke

Most Recent Events

  • 03 Aug 2007 Discontinued - Phase-I for Alzheimer's disease in Europe (unspecified route)
  • 03 Aug 2007 Discontinued - Phase-I for Dementia in Europe (unspecified route)
  • 03 Aug 2007 Discontinued - Phase-II for Stroke in Argentina (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top